{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:47:28Z","timestamp":1792162048381,"version":"4.4.0"},"reference-count":207,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Rev. Neurosci."],"DOI":"10.1038\/s41583-026-01085-7","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:02:29Z","timestamp":1792152149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The endocannabinoid system and the ageing brain"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6618-6264","authenticated-orcid":false,"given":"Andreas","family":"Zimmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"1085_CR1","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/geront\/gnv130","volume":"55","author":"EM Crimmins","year":"2015","unstructured":"Crimmins, E. M. Lifespan and healthspan: past, present, and promise. Gerontol 55, 901\u2013911 (2015).","journal-title":"Gerontol"},{"key":"1085_CR2","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"G Collaborators","year":"2024","unstructured":"Collaborators, G. et al. Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 23, 344\u2013381 (2024).","journal-title":"Lancet Neurol."},{"key":"1085_CR3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41586-019-1365-2","volume":"571","author":"J Campisi","year":"2019","unstructured":"Campisi, J. et al. From discoveries in ageing research to therapeutics for healthy ageing. Nature 571, 183\u2013192 (2019). This review article summarizes important findings from research into ageing processes, including therapeutic interventions to increase healthspan.","journal-title":"Nature"},{"key":"1085_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41586-018-0457-8","volume":"561","author":"L Partridge","year":"2018","unstructured":"Partridge, L., Deelen, J. & Slagboom, P. E. Facing up to the global challenges of ageing. Nature 561, 45\u201356 (2018).","journal-title":"Nature"},{"key":"1085_CR5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","volume":"186","author":"C L\u00f3pez-Ot\u00edn","year":"2023","unstructured":"L\u00f3pez-Ot\u00edn, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. Hallmarks of aging: an expanding universe. Cell 186, 243\u2013278 (2023). This review is an update of the classic 2013 paper defining core cellular and molecular mechanisms (\u2018hallmarks\u2019) that contribute to ageing.","journal-title":"Cell"},{"key":"1085_CR6","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","volume":"153","author":"C L\u00f3pez-Ot\u00edn","year":"2013","unstructured":"L\u00f3pez-Ot\u00edn, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. The hallmarks of aging. Cell 153, 1194\u20131217 (2013).","journal-title":"Cell"},{"key":"1085_CR7","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41392-022-01251-0","volume":"7","author":"J Guo","year":"2022","unstructured":"Guo, J. et al. Aging and aging-related diseases: From molecular mechanisms to interventions and treatments. Signal. Transduct. Target. Ther. 7, 391 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"1085_CR8","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104199","volume":"25","author":"D Promislow","year":"2022","unstructured":"Promislow, D. et al. Resilience integrates concepts in aging research. iScience 25, 104199 (2022).","journal-title":"iScience"},{"key":"1085_CR9","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/acel.12601","volume":"16","author":"SS Khan","year":"2017","unstructured":"Khan, S. S., Singer, B. D. & Vaughan, D. E. Molecular and physiological manifestations and measurement of aging in humans. Aging Cell 16, 624\u2013633 (2017).","journal-title":"Aging Cell"},{"key":"1085_CR10","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1124\/pharmrev.122.000600","volume":"75","author":"M Maccarrone","year":"2023","unstructured":"Maccarrone, M. et al. Goods and bads of the endocannabinoid system as a therapeutic target: Lessons learned after 30 years. Pharmacol. Rev. 75, 885\u2013958 (2023). This comprehensive and authorative review critically summarizes research on the therapeutic targeting of the endocannabinoid system, highlighting both its broad clinical potential, the pharmacological complexity and safety challenges.","journal-title":"Pharmacol. Rev."},{"key":"1085_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrn3876","volume":"16","author":"VD Marzo","year":"2014","unstructured":"Marzo, V. D., Stella, N. & Zimmer, A. Endocannabinoid signalling and the deteriorating brain. Nat. Rev. Neurosci. 16, 30\u201342 (2014).","journal-title":"Nat. Rev. Neurosci."},{"key":"1085_CR12","first-page":"607","volume":"6","author":"H-C Lu","year":"2021","unstructured":"Lu, H.-C. & Mackie, K. Review of the endocannabinoid system. Biol. Psychiatry Cogn. Neurosci. Neuroimaging 6, 607\u2013615 (2021).","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"1085_CR13","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1046\/j.1460-9568.1999.00847.x","volume":"11","author":"G Marsicano","year":"1999","unstructured":"Marsicano, G. & Lutz, B. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur. J. Neurosci. 11, 4213\u20134225 (1999).","journal-title":"Eur. J. Neurosci."},{"key":"1085_CR14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/glia.24246","volume":"71","author":"A Eraso-Pichot","year":"2023","unstructured":"Eraso-Pichot, A. et al. Endocannabinoid signaling in astrocytes. Glia 71, 44\u201359 (2023).","journal-title":"Glia"},{"key":"1085_CR15","doi-asserted-by":"crossref","first-page":"20130599","DOI":"10.1098\/rstb.2013.0599","volume":"369","author":"M Navarrete","year":"2014","unstructured":"Navarrete, M., D\u00edez, A. & Araque, A. Astrocytes in endocannabinoid signalling. Philos. Trans. R. Soc. Lond. B 369, 20130599 (2014).","journal-title":"Philos. Trans. R. Soc. Lond. B"},{"key":"1085_CR16","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.neuron.2008.01.029","volume":"57","author":"M Navarrete","year":"2008","unstructured":"Navarrete, M. & Araque, A. Endocannabinoids mediate neuron-astrocyte communication. Neuron 57, 883\u2013893 (2008).","journal-title":"Neuron"},{"key":"1085_CR17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neuron.2010.08.043","volume":"68","author":"M Navarrete","year":"2010","unstructured":"Navarrete, M. & Araque, A. Endocannabinoids potentiate synaptic transmission through stimulation of astrocytes. Neuron 68, 113\u2013126 (2010).","journal-title":"Neuron"},{"key":"1085_CR18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/bs.apha.2017.03.007","volume":"80","author":"AC Howlett","year":"2017","unstructured":"Howlett, A. C. & Abood, M. E. Chapter five CB1 and CB2 receptor pharmacology. Adv. Pharmacol. 80, 169\u2013206 (2017).","journal-title":"Adv. Pharmacol."},{"key":"1085_CR19","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.2174\/092986710790980023","volume":"17","author":"A Howlett","year":"2010","unstructured":"Howlett, A., Blume, L. & Dalton, G. CB1 cannabinoid receptors and their associated proteins. Curr. Med. Chem. 17, 1382\u20131393 (2010).","journal-title":"Curr. Med. Chem."},{"key":"1085_CR20","doi-asserted-by":"crossref","first-page":"7693","DOI":"10.3390\/ijms21207693","volume":"21","author":"D Haspula","year":"2020","unstructured":"Haspula, D. & Clark, M. A. Cannabinoid receptors: An update on cell signaling, pathophysiological roles and therapeutic opportunities in neurological, cardiovascular, and inflammatory diseases. Int. J. Mol. Sci. 21, 7693 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1085_CR21","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/s41593-023-01345-0","volume":"26","author":"E Albarran","year":"2023","unstructured":"Albarran, E. et al. Postsynaptic synucleins mediate endocannabinoid signaling. Nat. Neurosci. 26, 997\u20131007 (2023).","journal-title":"Nat. Neurosci."},{"key":"1085_CR22","doi-asserted-by":"crossref","first-page":"e2421717122","DOI":"10.1073\/pnas.2421717122","volume":"122","author":"VM Straub","year":"2025","unstructured":"Straub, V. M. et al. The endocannabinoid 2-arachidonoylglycerol is released and transported on demand via extracellular microvesicles. Proc. Natl Acad. Sci. USA 122, e2421717122 (2025).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1085_CR23","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/s41583-025-00961-y","volume":"26","author":"N Loomba","year":"2025","unstructured":"Loomba, N. & Patel, S. Circuit mechanisms governing endocannabinoid modulation of affective behaviour and stress adaptation. Nat. Rev. Neurosci. 26, 677\u2013697 (2025).","journal-title":"Nat. Rev. Neurosci."},{"key":"1085_CR24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/npp.2017.206","volume":"43","author":"A Busquets-Garcia","year":"2018","unstructured":"Busquets-Garcia, A., Bains, J. & Marsicano, G. CB1 receptor signaling in the brain: extracting specificity from ubiquity. Neuropsychopharmacology 43, 4\u201320 (2018).","journal-title":"Neuropsychopharmacology"},{"key":"1085_CR25","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nn1251","volume":"7","author":"S Mato","year":"2004","unstructured":"Mato, S. et al. A single in-vivo exposure to \u03949THC blocks endocannabinoid-mediated synaptic plasticity. Nat. Neurosci. 7, 585\u2013586 (2004).","journal-title":"Nat. Neurosci."},{"key":"1085_CR26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fnbeh.2011.00057","volume":"5","author":"C Zanettini","year":"2011","unstructured":"Zanettini, C. et al. Effects of endocannabinoid system modulation on cognitive and emotional behavior. Front. Behav. Neurosci. 5, 57 (2011).","journal-title":"Front. Behav. Neurosci."},{"key":"1085_CR27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/7854_2024_550","volume":"76","author":"K Monory","year":"2024","unstructured":"Monory, K., Ruiz de Azua, I. & Lutz, B. Behavioral impact of cannabinoids. Curr. Top. Behav. Neurosci. 76, 145\u2013207 (2024).","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"1085_CR28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/978-3-319-20825-1_5","volume":"231","author":"A Zimmer","year":"2015","unstructured":"Zimmer, A. Genetic manipulation of the endocannabinoid system. Handb. Exp. Pharmacol. 231, 129\u2013183 (2015).","journal-title":"Handb. Exp. Pharmacol."},{"key":"1085_CR29","doi-asserted-by":"crossref","first-page":"13420","DOI":"10.1523\/JNEUROSCI.2075-11.2011","volume":"31","author":"B Pan","year":"2011","unstructured":"Pan, B. et al. Alterations of endocannabinoid signaling, synaptic plasticity, learning, and memory in monoacylglycerol lipase knock-out mice. J. Neurosci. 31, 13420\u201313430 (2011).","journal-title":"J. Neurosci."},{"key":"1085_CR30","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.nlm.2009.06.001","volume":"92","author":"LE Wise","year":"2009","unstructured":"Wise, L. E., Harloe, J. P. & Lichtman, A. H. Fatty acid amide hydrolase (FAAH) knockout mice exhibit enhanced acquisition of an aversive, but not of an appetitive, Barnes maze task. Neurobiol. Learn. Mem. 92, 597\u2013601 (2009).","journal-title":"Neurobiol. Learn. Mem."},{"key":"1085_CR31","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1124\/jpet.301.3.915","volume":"301","author":"SA Varvel","year":"2002","unstructured":"Varvel, S. A. & Lichtman, A. H. Evaluation of CB1 receptor knockout mice in the Morris water maze. J. Pharmacol. Exp. Ther. 301, 915\u2013924 (2002).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"1085_CR32","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/2261171b0","volume":"226","author":"JR Tinklenberg","year":"1970","unstructured":"Tinklenberg, J. R., Melges, F. T., Hollister, L. E. & Gillespie, H. K. Marijuana and immediate memory. Nature 226, 1171\u20131172 (1970).","journal-title":"Nature"},{"key":"1085_CR33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrn.2016.28","volume":"17","author":"HV Curran","year":"2016","unstructured":"Curran, H. V. et al. Keep off the grass? Cannabis, cognition and addiction. Nat. Rev. Neurosci. 17, 293\u2013306 (2016).","journal-title":"Nat. Rev. Neurosci."},{"key":"1085_CR34","doi-asserted-by":"crossref","first-page":"e12920","DOI":"10.1111\/eci.12920","volume":"48","author":"EJ Calabrese","year":"2018","unstructured":"Calabrese, E. J. & Rubio-Casillas, A. Biphasic effects of THC in memory and cognition. Eur. J. Clin. Invest. 48, e12920 (2018).","journal-title":"Eur. J. Clin. Invest."},{"key":"1085_CR35","doi-asserted-by":"crossref","first-page":"114384","DOI":"10.1016\/j.expneurol.2023.114384","volume":"364","author":"A Figueiredo","year":"2023","unstructured":"Figueiredo, A. & Cheer, J. F. Endocannabinoid regulation of hippocampus-dependent memory. Exp. Neurol. 364, 114384 (2023).","journal-title":"Exp. Neurol."},{"key":"1085_CR36","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1016\/j.neuron.2025.03.016","volume":"113","author":"S Malhotra","year":"2025","unstructured":"Malhotra, S. et al. Integrating endocannabinoid signaling, CCK interneurons, and hippocampal circuit dynamics in behaving animals. Neuron 113, 1862\u20131885 (2025).","journal-title":"Neuron"},{"key":"1085_CR37","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.cell.2012.01.037","volume":"148","author":"J Han","year":"2012","unstructured":"Han, J. et al. Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD. Cell 148, 1039\u20131050 (2012). This paper provides evidence that marijuana can impair working memory by through the activation of astroglial CB1 receptors by disrupting astroglia-dependent hippocampal LTD.","journal-title":"Cell"},{"key":"1085_CR38","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1111\/febs.15907","volume":"289","author":"A Robledo-Menendez","year":"2022","unstructured":"Robledo-Menendez, A., Vella, M., Grandes, P. & Soria-Gomez, E. Cannabinoid control of hippocampal functions: the where matters. FEBS J. 289, 2162\u20132175 (2022).","journal-title":"FEBS J."},{"key":"1085_CR39","doi-asserted-by":"crossref","first-page":"7993","DOI":"10.1523\/JNEUROSCI.6238-09.2010","volume":"30","author":"S-H Lee","year":"2010","unstructured":"Lee, S.-H., F\u00f6ldy, C. & Soltesz, I. Distinct endocannabinoid control of GABA release at perisomatic and dendritic synapses in the hippocampus. J. Neurosci. 30, 7993\u20138000 (2010).","journal-title":"J. Neurosci."},{"key":"1085_CR40","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.tins.2013.04.007","volume":"36","author":"KJ Iremonger","year":"2013","unstructured":"Iremonger, K. J., Cusulin, J. I. W. & Bains, J. S. Changing the tune: plasticity and adaptation of retrograde signals. Trends Neurosci. 36, 471\u2013479 (2013).","journal-title":"Trends Neurosci."},{"key":"1085_CR41","first-page":"34","volume":"5","author":"I Akirav","year":"2011","unstructured":"Akirav, I. The role of cannabinoids in modulating emotional and non-emotional memory processes in the hippocampus. Front. Behav. Neurosci. 5, 34 (2011).","journal-title":"Front. Behav. Neurosci."},{"key":"1085_CR42","doi-asserted-by":"crossref","first-page":"e2457069","DOI":"10.1001\/jamanetworkopen.2024.57069","volume":"8","author":"JL Gowin","year":"2025","unstructured":"Gowin, J. L. et al. Brain function outcomes of recent and lifetime cannabis use. JAMA Netw. Open 8, e2457069 (2025).","journal-title":"JAMA Netw. Open"},{"key":"1085_CR43","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/nm.4311","volume":"23","author":"A Bilkei-Gorz\u00f3","year":"2017","unstructured":"Bilkei-Gorz\u00f3, A. et al. A chronic low dose of \u03949-tetrahydrocannabinol (THC) restores cognitive function in old mice. Nat. Med. 23, 782\u2013787 (2017). This paper demonstrates that long term CB1 receptor activation by a continuous THC infusion can improve cognitive functions in old animals, whereas the same treatment has the opposite effect in young animals.","journal-title":"Nat. Med."},{"key":"1085_CR44","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1098\/rstb.2011.0388","volume":"367","author":"A Bilkei-Gorz\u00f3","year":"2012","unstructured":"Bilkei-Gorz\u00f3, A. The endocannabinoid system in normal and pathological brain ageing. Philos. Trans. R. Soc. Lond. B 367, 3326\u20133341 (2012).","journal-title":"Philos. Trans. R. Soc. Lond. B"},{"key":"1085_CR45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41514-023-00120-6","volume":"9","author":"DVC Brito","year":"2023","unstructured":"Brito, D. V. C. et al. Assessing cognitive decline in the aging brain: Lessons from rodent and human studies. npj Aging 9, 23 (2023). This review identifies conserved domains of age-related cognitive decline in rodents and humans, aiming to improve translation between preclinical studies and clinical trials.","journal-title":"npj Aging"},{"key":"1085_CR46","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.neurobiolaging.2019.07.012","volume":"84","author":"AN Trelle","year":"2019","unstructured":"Trelle, A. N., Henson, R. N. & Simons, J. S. Neural evidence for age-related differences in representational quality and strategic retrieval processes. Neurobiol. Aging 84, 50\u201360 (2019).","journal-title":"Neurobiol. Aging"},{"key":"1085_CR47","doi-asserted-by":"crossref","first-page":"1012870","DOI":"10.3389\/fnagi.2022.1012870","volume":"14","author":"S Cansino","year":"2022","unstructured":"Cansino, S. Brain connectivity changes associated with episodic recollection decline in aging: A review of fMRI studies. Front. Aging Neurosci. 14, 1012870 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"1085_CR48","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1037\/0882-7974.23.1.104","volume":"23","author":"SR Old","year":"2008","unstructured":"Old, S. R. & Naveh-Benjamin, M. Differential effects of age on item and associative measures of memory: a meta-analysis. Psychol. Aging 23, 104\u2013118 (2008).","journal-title":"Psychol. Aging"},{"key":"1085_CR49","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fneur.2012.00008","volume":"3","author":"C Harand","year":"2012","unstructured":"Harand, C. et al. How aging affects sleep-dependent memory consolidation? Front. Neurol. 3, 8 (2012).","journal-title":"Front. Neurol."},{"key":"1085_CR50","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1037\/bul0000185","volume":"145","author":"SH Fraundorf","year":"2019","unstructured":"Fraundorf, S. H., Hourihan, K. L., Peters, R. A. & Benjamin, A. S. Aging and recognition memory: a meta-analysis. Psychol. Bull. 145, 339\u2013371 (2019).","journal-title":"Psychol. Bull."},{"key":"1085_CR51","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/02698811261416079","volume":"40","author":"C Cuttler","year":"2026","unstructured":"Cuttler, C. & McLaughlin, R. J. Mapping the acute effects of cannabis on multiple memory domains: a randomized, double-blind, placebo-controlled study. J. Psychopharmacol. 40, 410\u2013421 (2026).","journal-title":"J. Psychopharmacol."},{"key":"1085_CR52","doi-asserted-by":"crossref","first-page":"6515","DOI":"10.1073\/pnas.1504162112","volume":"112","author":"F McNab","year":"2015","unstructured":"McNab, F. et al. Age-related changes in working memory and the ability to ignore distraction. Proc. Natl Acad. Sci. USA 112, 6515\u20136518 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1085_CR53","doi-asserted-by":"crossref","first-page":"1231410","DOI":"10.3389\/fnagi.2023.1231410","volume":"15","author":"M Dexter","year":"2023","unstructured":"Dexter, M. & Ossmy, O. The effects of typical ageing on cognitive control: Recent advances and future directions. Front. Aging Neurosci. 15, 1231410 (2023).","journal-title":"Front. Aging Neurosci."},{"key":"1085_CR54","doi-asserted-by":"crossref","first-page":"1334309","DOI":"10.3389\/fnagi.2024.1334309","volume":"16","author":"MI Idowu","year":"2024","unstructured":"Idowu, M. I., Szameitat, A. J. & Parton, A. The assessment of executive function abilities in healthy and neurodegenerative aging \u2014 a selective literature review. Front. Aging Neurosci. 16, 1334309 (2024).","journal-title":"Front. Aging Neurosci."},{"key":"1085_CR55","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1007\/s00426-023-01794-z","volume":"87","author":"E-H Chen","year":"2023","unstructured":"Chen, E.-H. & Hsieh, S. The effect of age on task switching: updated and extended meta-analyses. Psychol. Res. 87, 2011\u20132030 (2023).","journal-title":"Psychol. Res."},{"key":"1085_CR56","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/s43587-023-00469-z","volume":"3","author":"MJ Dahl","year":"2023","unstructured":"Dahl, M. J. et al. The integrity of dopaminergic and noradrenergic brain regions is associated with different aspects of late-life memory performance. Nat. Aging 3, 1128\u20131143 (2023).","journal-title":"Nat. Aging"},{"key":"1085_CR57","doi-asserted-by":"crossref","first-page":"110063","DOI":"10.1016\/j.pnpbp.2020.110063","volume":"104","author":"S Zhornitsky","year":"2021","unstructured":"Zhornitsky, S. et al. Acute effects of partial CB1 receptor agonists on cognition \u2014 a meta-analysis of human studies. Prog. Neuropsychopharmacol. Biol. Psychiatry 104, 110063 (2021).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"1085_CR58","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/add.15764","volume":"117","author":"L Dellazizzo","year":"2022","unstructured":"Dellazizzo, L., Potvin, S., Gigu\u00e8re, S. & Dumais, A. Evidence on the acute and residual neurocognitive effects of cannabis use in adolescents and adults: a systematic meta-review of meta-analyses. Addiction 117, 1857\u20131870 (2022).","journal-title":"Addiction"},{"key":"1085_CR59","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0893-133X(97)00018-3","volume":"16","author":"JD Jentsch","year":"1997","unstructured":"Jentsch, J. D., Andrusiak, E., Tran, A., Bowers, M. B. & Roth, R. H. \u03949-Tetrahydrocannabinol increases prefrontal cortical catecholaminergic utilization and impairs spatial working memory in the rat: blockade of dopaminergic effects with HA966. Neuropsychopharmacology 16, 426\u2013432 (1997).","journal-title":"Neuropsychopharmacology"},{"key":"1085_CR60","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/sj.bjp.0705100","volume":"138","author":"ET Tzavara","year":"2003","unstructured":"Tzavara, E. T. et al. The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: Implications for therapeutic actions. Br. J. Pharmacol. 138, 544\u2013553 (2003).","journal-title":"Br. J. Pharmacol."},{"key":"1085_CR61","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.neubiorev.2005.12.002","volume":"30","author":"A Egerton","year":"2006","unstructured":"Egerton, A., Allison, C., Brett, R. R. & Pratt, J. A. Cannabinoids and prefrontal cortical function: Insights from preclinical studies. Neurosci. Biobehav. Rev. 30, 680\u2013695 (2006).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"1085_CR62","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jamapsychiatry.2018.0335","volume":"75","author":"JC Scott","year":"2018","unstructured":"Scott, J. C. et al. Association of cannabis with cognitive functioning in adolescents and young adults: a systematic review and meta-analysis. JAMA Psychiatry 75, 585 (2018).","journal-title":"JAMA Psychiatry"},{"key":"1085_CR63","first-page":"1","volume":"57","author":"ND Volkow","year":"2016","unstructured":"Volkow, N. D., Hampson, A. J. & Baler, R. Don\u2019t worry, be happy: endocannabinoids and cannabis at the intersection of stress and reward. Annu. Rev. Pharmacol. Toxicol. 57, 1\u201323 (2016).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"1085_CR64","doi-asserted-by":"crossref","first-page":"100912","DOI":"10.1016\/j.arr.2019.100912","volume":"53","author":"L Nguyen","year":"2019","unstructured":"Nguyen, L., Murphy, K. & Andrews, G. Cognitive and neural plasticity in old age: a systematic review of evidence from executive functions cognitive training. Ageing Res. Rev. 53, 100912 (2019).","journal-title":"Ageing Res. Rev."},{"key":"1085_CR65","doi-asserted-by":"crossref","first-page":"102569","DOI":"10.1016\/j.arr.2024.102569","volume":"102","author":"J Gooijers","year":"2024","unstructured":"Gooijers, J. et al. Aging, brain plasticity, and motor learning. Ageing Res. Rev. 102, 102569 (2024).","journal-title":"Ageing Res. Rev."},{"key":"1085_CR66","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nrn4036","volume":"16","author":"B Lutz","year":"2015","unstructured":"Lutz, B., Marsicano, G., Maldonado, R. & Hillard, C. J. The endocannabinoid system in guarding against fear, anxiety and stress. Nat. Rev. Neurosci. 16, 705\u2013718 (2015).","journal-title":"Nat. Rev. Neurosci."},{"key":"1085_CR67","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/nature00839","volume":"418","author":"G Marsicano","year":"2002","unstructured":"Marsicano, G. et al. The endogenous cannabinoid system controls extinction of aversive memories. Nature 418, 530\u2013534 (2002).","journal-title":"Nature"},{"key":"1085_CR68","doi-asserted-by":"crossref","first-page":"15670","DOI":"10.1073\/pnas.0504640102","volume":"102","author":"A Bilkei-Gorzo","year":"2005","unstructured":"Bilkei-Gorzo, A. et al. Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors. Proc. Natl Acad. Sci. USA. 102, 15670\u201315675 (2005).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"1085_CR69","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fnagi.2012.00034","volume":"4","author":"O Albayram","year":"2012","unstructured":"Albayram, O., Bilkei-Gorz\u00f3, A. & Zimmer, A. Loss of CB1 receptors leads to differential age-related changes in reward-driven learning and memory. Front. Aging Neurosci. 4, 34 (2012).","journal-title":"Front. Aging Neurosci."},{"key":"1085_CR70","doi-asserted-by":"crossref","first-page":"11256","DOI":"10.1073\/pnas.1016442108","volume":"108","author":"O Albayram","year":"2011","unstructured":"Albayram, O. et al. Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging. Proc. Natl Acad. Sci. USA. 108, 11256\u201311261 (2011).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"1085_CR71","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/nn.2369","volume":"12","author":"E Puighermanal","year":"2009","unstructured":"Puighermanal, E. et al. Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling. Nat. Neurosci. 12, 1152\u20131158 (2009).","journal-title":"Nat. Neurosci."},{"key":"1085_CR72","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1471-4159.2009.06489.x","volume":"112","author":"N Fan","year":"2010","unstructured":"Fan, N., Yang, H., Zhang, J. & Chen, C. Reduced expression of glutamate receptors and phosphorylation of CREB are responsible for in vivo \u03949-THC exposure-impaired hippocampal synaptic plasticity. J. Neurochem. 112, 691\u2013702 (2010).","journal-title":"J. Neurochem."},{"key":"1085_CR73","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.cell.2013.10.042","volume":"155","author":"R Chen","year":"2013","unstructured":"Chen, R. et al. \u03949-THC-caused synaptic and memory impairments are mediated through COX-2 signaling. Cell 155, 1154\u20131165 (2013).","journal-title":"Cell"},{"key":"1085_CR74","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.neuropharm.2012.06.063","volume":"64","author":"CA Rabinak","year":"2013","unstructured":"Rabinak, C. A. et al. Cannabinoid facilitation of fear extinction memory recall in humans. Neuropharmacology 64, 396\u2013402 (2013).","journal-title":"Neuropharmacology"},{"key":"1085_CR75","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/7854_2025_597","volume":"76","author":"J Fern\u00e1ndez-Ruiz","year":"2025","unstructured":"Fern\u00e1ndez-Ruiz, J., Sagredo, O., G\u00f3mez-Ruiz, M. & de Lago, E. Behavioral impact of cannabinoids. Curr. Top. Behav. Neurosci. 76, 209\u2013248 (2025).","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"1085_CR76","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0892-0362(94)00053-G","volume":"17","author":"RC Belue","year":"1995","unstructured":"Belue, R. C., Howlett, A. C., Westlake, T. M. & Hutchings, D. E. The ontogeny of cannabinoid receptors in the brain of postnatal and aging rats. Neurotoxicol. Teratol. 17, 25\u201330 (1995).","journal-title":"Neurotoxicol. Teratol."},{"key":"1085_CR77","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.mad.2015.08.005","volume":"150","author":"A Piyanova","year":"2015","unstructured":"Piyanova, A. et al. Age-related changes in the endocannabinoid system in the mouse hippocampus. Mech. Ageing Dev. 150, 55\u201364 (2015).","journal-title":"Mech. Ageing Dev."},{"key":"1085_CR78","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/syn.20844","volume":"65","author":"L Heng","year":"2011","unstructured":"Heng, L., Beverley, J. A., Steiner, H. & Tseng, K. Y. Differential developmental trajectories for CB1 cannabinoid receptor expression in limbic\/associative and sensorimotor cortical areas. Synapse 65, 278\u2013286 (2011).","journal-title":"Synapse"},{"key":"1085_CR79","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0006-8993(03)02872-5","volume":"979","author":"P Liu","year":"2003","unstructured":"Liu, P., Bilkey, D. K., Darlington, C. L. & Smith, P. F. Cannabinoid CB1 receptor protein expression in the rat hippocampus and entorhinal, perirhinal, postrhinal and temporal cortices: regional variations and age-related changes. Brain Res. 979, 235\u2013239 (2003).","journal-title":"Brain Res."},{"key":"1085_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-0832-8","volume":"10","author":"R Tao","year":"2020","unstructured":"Tao, R. et al. Cannabinoid receptor CNR1 expression and DNA methylation in human prefrontal cortex, hippocampus and caudate in brain development and schizophrenia. Transl. Psychiatry 10, 158 (2020).","journal-title":"Transl. Psychiatry"},{"key":"1085_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-13-87","volume":"13","author":"LE Long","year":"2012","unstructured":"Long, L. E., Lind, J., Webster, M. & Weickert, C. S. Developmental trajectory of the endocannabinoid system in human dorsolateral prefrontal cortex. BMC Neurosci. 13, 87 (2012).","journal-title":"BMC Neurosci."},{"key":"1085_CR82","doi-asserted-by":"crossref","first-page":"119674","DOI":"10.1016\/j.neuroimage.2022.119674","volume":"264","author":"R Radhakrishnan","year":"2022","unstructured":"Radhakrishnan, R. et al. Age, gender and body-mass-index relationships with in vivo CB1 receptor availability in healthy humans measured with [11C]OMAR PET. NeuroImage 264, 119674 (2022).","journal-title":"NeuroImage"},{"key":"1085_CR83","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.neuroimage.2007.10.053","volume":"39","author":"KV Laere","year":"2008","unstructured":"Laere, K. V. et al. Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [18F]MK-9470 PET. Neuroimage 39, 1533\u20131541 (2008).","journal-title":"Neuroimage"},{"key":"1085_CR84","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0306-4522(94)90511-8","volume":"63","author":"TM Westlake","year":"1994","unstructured":"Westlake, T. M., Howlett, A. C., Bonner, T. I., Matsuda, L. A. & Herkenham, M. Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer\u2019s brains. Neuroscience 63, 637\u2013652 (1994). This early human autoradiographic study identified age- and pathology-associated reductions in CB1 receptor binding, particularly in the hippocampus and basal ganglia.","journal-title":"Neuroscience"},{"key":"1085_CR85","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1073\/pnas.0336351100","volume":"100","author":"L Wang","year":"2003","unstructured":"Wang, L., Liu, J., Harvey-White, J., Zimmer, A. & Kunos, G. Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc. Natl Acad. Sci. USA 100, 1393\u20131398 (2003). This paper provides early evidence for functional differences in CB1 receptor signaling between young and old mice.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1085_CR86","doi-asserted-by":"crossref","first-page":"10254","DOI":"10.3390\/ijms231810254","volume":"23","author":"P Nidadavolu","year":"2022","unstructured":"Nidadavolu, P. et al. Dynamic changes in the endocannabinoid system during the aging process: focus on the middle-age crisis. Int. J. Mol. Sci. 23, 10254 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1085_CR87","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0925-4439(98)00042-8","volume":"1407","author":"F Berrendero","year":"1998","unstructured":"Berrendero, F. et al. Changes in cannabinoid receptor binding and mRNA levels in several brain regions of aged rats. Biochim. Biophys. Acta 1407, 205\u2013214 (1998).","journal-title":"Biochim. Biophys. Acta"},{"key":"1085_CR88","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/cne.25427","volume":"531","author":"X Li","year":"2023","unstructured":"Li, X. et al. Lifespan changes in cannabinoid 1 receptor mRNA expression in the female C57BL\/6J mouse brain. J. Comp. Neurol. 531, 294\u2013313 (2023).","journal-title":"J. Comp. Neurol."},{"key":"1085_CR89","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.neuropharm.2003.11.004","volume":"46","author":"S Mato","year":"2004","unstructured":"Mato, S. & Pazos, A. Influence of age, postmortem delay and freezing storage period on cannabinoid receptor density and functionality in human brain. Neuropharmacology 46, 716\u2013726 (2004).","journal-title":"Neuropharmacology"},{"key":"1085_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-27618-1","volume":"16","author":"AWJ Morris","year":"2026","unstructured":"Morris, A. W. J. et al. Age differences in endocannabinoid tone are ameliorated after recent cannabis use. Sci. Rep. 16, 3483 (2026).","journal-title":"Sci. Rep."},{"key":"1085_CR91","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.euroneuro.2019.03.010","volume":"29","author":"MG Bossong","year":"2019","unstructured":"Bossong, M. G. et al. Acute effects of \u22069-tetrahydrocannabinol (THC) on resting state brain function and their modulation by COMT genotype. Eur. Neuropsychopharmacol. 29, 766\u2013776 (2019).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"1085_CR92","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.biopsych.2005.01.026","volume":"57","author":"A Caspi","year":"2005","unstructured":"Caspi, A. et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol. Psychiatry 57, 1117\u20131127 (2005).","journal-title":"Biol. Psychiatry"},{"key":"1085_CR93","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0306-4522(97)00552-6","volume":"84","author":"J Romero","year":"1998","unstructured":"Romero, J. et al. Loss of cannabinoid receptor binding and messenger RNA levels and cannabinoid agonist-stimulated [35S]guanylyl-5\u2019O-(thio)-triphosphate binding in the basal ganglia of aged rats. Neuroscience 84, 1075\u20131083 (1998).","journal-title":"Neuroscience"},{"key":"1085_CR94","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1111\/j.1471-4159.2007.04668.x","volume":"102","author":"N Sang","year":"2007","unstructured":"Sang, N., Zhang, J. & Chen, C. COX-2 oxidative metabolite of endocannabinoid 2-AG enhances excitatory glutamatergic synaptic transmission and induces neurotoxicity. J. Neurochem. 102, 1966\u20131977 (2007).","journal-title":"J. Neurochem."},{"key":"1085_CR95","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41586-020-03160-0","volume":"590","author":"PS Minhas","year":"2021","unstructured":"Minhas, P. S. et al. Restoring metabolism of myeloid cells reverses cognitive decline in ageing. Nature 590, 122\u2013128 (2021).","journal-title":"Nature"},{"key":"1085_CR96","doi-asserted-by":"crossref","first-page":"200.e11","DOI":"10.1016\/j.neurobiolaging.2010.07.009","volume":"33","author":"A Bilkei-Gorz\u00f3","year":"2012","unstructured":"Bilkei-Gorz\u00f3, A. et al. Early onset of aging-like changes is restricted to cognitive abilities and skin structure in Cnr1\u2212\/\u2212 mice. Neurobiol. Aging 33, 200.e11\u201322 (2012).","journal-title":"Neurobiol. Aging"},{"key":"1085_CR97","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1523\/JNEUROSCI.1353-18.2019","volume":"39","author":"LD Schurman","year":"2019","unstructured":"Schurman, L. D. et al. Diacylglycerol lipase-alpha regulates hippocampal-dependent learning and memory processes in mice. J. Neurosci. 39, 5949\u20135965 (2019).","journal-title":"J. Neurosci."},{"key":"1085_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2015.03.033","author":"I Jenniches","year":"2015","unstructured":"Jenniches, I. et al. Anxiety, stress, and fear response in mice with reduced endocannabinoid levels. Biol. Psychiatry https:\/\/doi.org\/10.1016\/j.biopsych.2015.03.033 (2015).","journal-title":"Biol. Psychiatry"},{"key":"1085_CR99","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2018.00295","volume":"11","author":"F Ativie","year":"2018","unstructured":"Ativie, F. et al. Cannabinoid 1 receptor signaling on hippocampal GABAergic neurons influences microglial activity. Front. Mol. Neurosci. 11, 295 (2018).","journal-title":"Front. Mol. Neurosci."},{"key":"1085_CR100","doi-asserted-by":"crossref","first-page":"e0202566","DOI":"10.1371\/journal.pone.0202566","volume":"13","author":"A Bilkei-Gorz\u00f3","year":"2018","unstructured":"Bilkei-Gorz\u00f3, A. et al. Cannabinoid 1 receptor signaling on GABAergic neurons influences astrocytes in the ageing brain. PLoS ONE 13, e0202566 (2018).","journal-title":"PLoS ONE"},{"key":"1085_CR101","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/ijms24010026","volume":"24","author":"M Palmisano","year":"2022","unstructured":"Palmisano, M., Gargano, A., Olabiyi, B. F., Lutz, B. & Bilkei-Gorzo, A. Hippocampal deletion of CB1 receptor impairs social memory and leads to age-related changes in the hippocampus of adult mice. Int. J. Mol. Sci. 24, 26 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1085_CR102","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","volume":"14","author":"C Franceschi","year":"2018","unstructured":"Franceschi, C., Garagnani, P., Parini, P., Giuliani, C. & Santoro, A. Inflammaging: a new immune\u2013metabolic viewpoint for age-related diseases. Nat. Rev. Endocrinol. 14, 576\u2013590 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1085_CR103","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/s41580-024-00727-x","volume":"25","author":"B Wang","year":"2024","unstructured":"Wang, B., Han, J., Elisseeff, J. H. & Demaria, M. The senescence-associated secretory phenotype and its physiological and pathological implications. Nat. Rev. Mol. Cell Biol. 25, 958\u2013978 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1085_CR104","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.neurobiolaging.2007.04.028","volume":"29","author":"Y Marchalant","year":"2008","unstructured":"Marchalant, Y., Cerbai, F., Brothers, H. M. & Wenk, G. L. Cannabinoid receptor stimulation is anti-inflammatory and improves memory in old rats. Neurobiol. Aging 29, 1894\u20131901 (2008).","journal-title":"Neurobiol. Aging"},{"key":"1085_CR105","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nn.3053","volume":"15","author":"G B\u00e9nard","year":"2012","unstructured":"B\u00e9nard, G. et al. Mitochondrial CB1 receptors regulate neuronal energy metabolism. Nat. Neurosci. 15, 558\u2013564 (2012).","journal-title":"Nat. Neurosci."},{"key":"1085_CR106","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-020-2470-y","volume":"583","author":"D Jimenez-Blasco","year":"2020","unstructured":"Jimenez-Blasco, D. et al. Glucose metabolism links astroglial mitochondria to cannabinoid effects. Nature 583, 603\u2013608 (2020).","journal-title":"Nature"},{"key":"1085_CR107","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1126\/science.1209200","volume":"334","author":"DK Nomura","year":"2011","unstructured":"Nomura, D. K. et al. Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation. Science 334, 809\u2013813 (2011).","journal-title":"Science"},{"key":"1085_CR108","doi-asserted-by":"crossref","first-page":"1715045","DOI":"10.3389\/fnagi.2025.1715045","volume":"17","author":"L M\u00fcller","year":"2025","unstructured":"M\u00fcller, L., Benedetto, S. D. & M\u00fcller, V. Neuroimmune dynamics and brain aging: mechanisms and consequences. Front. Aging Neurosci. 17, 1715045 (2025).","journal-title":"Front. Aging Neurosci."},{"key":"1085_CR109","doi-asserted-by":"crossref","first-page":"108394","DOI":"10.1016\/j.pharmthera.2023.108394","volume":"244","author":"C Chen","year":"2023","unstructured":"Chen, C. Inhibiting degradation of 2-arachidonoylglycerol as a therapeutic strategy for neurodegenerative diseases. Pharmacol. Ther. 244, 108394 (2023).","journal-title":"Pharmacol. Ther."},{"key":"1085_CR110","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nn.3079","volume":"15","author":"DA Lee","year":"2012","unstructured":"Lee, D. A. et al. Tanycytes of the hypothalamic median eminence form a diet-responsive neurogenic niche. Nat. Neurosci. 15, 700\u2013702 (2012).","journal-title":"Nat. Neurosci."},{"key":"1085_CR111","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1126\/science.adh8488","volume":"382","author":"H Fong","year":"2023","unstructured":"Fong, H., Zheng, J. & Kurrasch, D. The structural and functional complexity of the integrative hypothalamus. Science 382, 388\u2013394 (2023).","journal-title":"Science"},{"key":"1085_CR112","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.stem.2015.09.003","volume":"17","author":"AM Bond","year":"2015","unstructured":"Bond, A. M., Ming, G. & Song, H. Adult mammalian neural stem cells and neurogenesis: five decades later. Cell Stem Cell 17, 385\u2013395 (2015).","journal-title":"Cell Stem Cell"},{"key":"1085_CR113","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.stem.2020.07.002","volume":"27","author":"PN Negredo","year":"2020","unstructured":"Negredo, P. N., Yeo, R. W. & Brunet, A. Aging and rejuvenation of neural stem cells and their niches. Cell Stem Cell 27, 202\u2013223 (2020).","journal-title":"Cell Stem Cell"},{"key":"1085_CR114","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41580-022-00510-w","volume":"24","author":"A Brunet","year":"2023","unstructured":"Brunet, A., Goodell, M. A. & Rando, T. A. Ageing and rejuvenation of tissue stem cells and their niches. Nat. Rev. Mol. Cell Biol. 24, 45\u201362 (2023).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1085_CR115","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nrn3846","volume":"15","author":"M Maccarrone","year":"2014","unstructured":"Maccarrone, M., Guzm\u00e1n, M., Mackie, K., Doherty, P. & Harkany, T. Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies. Nat. Rev. Neurosci. 15, 786\u2013801 (2014).","journal-title":"Nat. Rev. Neurosci."},{"key":"1085_CR116","doi-asserted-by":"crossref","first-page":"101239","DOI":"10.1016\/j.plipres.2023.101239","volume":"91","author":"S Oddi","year":"2023","unstructured":"Oddi, S., Fiorenza, M. T. & Maccarrone, M. Endocannabinoid signaling in adult hippocampal neurogenesis: a mechanistic and integrated perspective. Prog. Lipid Res. 91, 101239 (2023).","journal-title":"Prog. Lipid Res."},{"key":"1085_CR117","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1111\/bph.13186","volume":"172","author":"JA Prenderville","year":"2015","unstructured":"Prenderville, J. A., Kelly, \u00c1. M. & Downer, E. J. The role of cannabinoids in adult neurogenesis. Br. J. Pharmacol. 172, 3950\u20133963 (2015).","journal-title":"Br. J. Pharmacol."},{"key":"1085_CR118","doi-asserted-by":"crossref","first-page":"10098","DOI":"10.1074\/jbc.M109.043711","volume":"285","author":"S Trazzi","year":"2010","unstructured":"Trazzi, S., Steger, M., Mitrugno, V. M., Bartesaghi, R. & Ciani, E. CB1 cannabinoid receptors increase neuronal precursor proliferation through AKT\/glycogen synthase kinase-3\u03b2\/\u03b2-catenin signaling. J. Biol. Chem. 285, 10098\u201310109 (2010).","journal-title":"J. Biol. Chem."},{"key":"1085_CR119","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1124\/mol.66.2.204","volume":"66","author":"K Jin","year":"2004","unstructured":"Jin, K. et al. Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice. Mol. Pharmacol. 66, 204\u2013208 (2004).","journal-title":"Mol. Pharmacol."},{"key":"1085_CR120","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1093\/cercor\/bhy258","volume":"28","author":"T Zimmermann","year":"2018","unstructured":"Zimmermann, T. et al. Neural stem cell lineage-specific cannabinoid type-1 receptor regulates neurogenesis and plasticity in the adult mouse hippocampus. Cereb. Cortex 28, 4454\u20134471 (2018).","journal-title":"Cereb. Cortex"},{"key":"1085_CR121","doi-asserted-by":"crossref","first-page":"23892","DOI":"10.1074\/jbc.M700678200","volume":"282","author":"T Aguado","year":"2007","unstructured":"Aguado, T. et al. The CB1 cannabinoid receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis. J. Biol. Chem. 282, 23892\u201323898 (2007).","journal-title":"J. Biol. Chem."},{"key":"1085_CR122","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1172\/JCI25509","volume":"115","author":"W Jiang","year":"2005","unstructured":"Jiang, W. et al. Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. J. Clin. Invest. 115, 3104\u20133116 (2005).","journal-title":"J. Clin. Invest."},{"key":"1085_CR123","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/mp.2009.62","volume":"14","author":"Y Marchalant","year":"2009","unstructured":"Marchalant, Y., Brothers, H. M. & Wenk, G. L. Cannabinoid agonist WIN-55,212-2 partially restores neurogenesis in the aged rat brain. Mol. Psychiatry 14, 1068\u20131069 (2009).","journal-title":"Mol. Psychiatry"},{"key":"1085_CR124","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1478-811X-8-12","volume":"8","author":"SA Wolf","year":"2010","unstructured":"Wolf, S. A. et al. Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis. Cell Commun. Signal. 8, 12 (2010).","journal-title":"Cell Commun. Signal."},{"key":"1085_CR125","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1523\/JNEUROSCI.5693-09.2010","volume":"30","author":"Y Gao","year":"2010","unstructured":"Gao, Y. et al. Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice. J. Neurosci. 30, 2017\u20132024 (2010).","journal-title":"J. Neurosci."},{"key":"1085_CR126","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-04600-1","volume":"12","author":"L-L Schuele","year":"2022","unstructured":"Schuele, L.-L. et al. Regulation of adult neurogenesis by the endocannabinoid-producing enzyme diacylglycerol lipase alpha (DAGLa). Sci. Rep. 12, 633 (2022).","journal-title":"Sci. Rep."},{"key":"1085_CR127","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fnagi.2011.00007","volume":"3","author":"A Kumar","year":"2011","unstructured":"Kumar, A. Long-term potentiation at CA3\u2013CA1 hippocampal synapses with special emphasis on aging, disease, and stress. Front. Aging Neurosci. 3, 7 (2011).","journal-title":"Front. Aging Neurosci."},{"key":"1085_CR128","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1523\/JNEUROSCI.3167-14.2015","volume":"35","author":"K Monory","year":"2015","unstructured":"Monory, K., Polack, M., Remus, A., Lutz, B. & Korte, M. Cannabinoid CB1 receptor calibrates excitatory synaptic balance in the mouse hippocampus. J. Neurosci. 35, 3842\u20133850 (2015).","journal-title":"J. Neurosci."},{"key":"1085_CR129","doi-asserted-by":"crossref","first-page":"e54812","DOI":"10.7554\/eLife.54812","volume":"9","author":"HR Monday","year":"2020","unstructured":"Monday, H. R., Bourdenx, M., Jordan, B. A. & Castillo, P. E. CB1-receptor-mediated inhibitory LTD triggers presynaptic remodeling via protein synthesis and ubiquitination. eLife 9, e54812 (2020).","journal-title":"eLife"},{"key":"1085_CR130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.biopsych.2021.03.023","volume":"90","author":"S Yoon","year":"2021","unstructured":"Yoon, S., Myczek, K. & Penzes, P. cAMP signaling-mediated phosphorylation of diacylglycerol lipase \u03b1 regulates interaction with ankyrin-G and dendritic spine morphology. Biol. Psychiatry 90, 263\u2013274 (2021).","journal-title":"Biol. Psychiatry"},{"key":"1085_CR131","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1002\/cne.25098","volume":"529","author":"IB R\u00edo","year":"2021","unstructured":"R\u00edo, I. B. et al. Acute \u03949-tetrahydrocannabinol prompts rapid changes in cannabinoid CB1 receptor immunolabeling and subcellular structure in CA1 hippocampus of young adult male mice. J. Comp. Neurol. 529, 2332\u20132346 (2021).","journal-title":"J. Comp. Neurol."},{"key":"1085_CR132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2017.07.015","volume":"1672","author":"TL Holland","year":"2017","unstructured":"Holland, T. L. & Soderstrom, K. Chronic CB1 cannabinoid receptor antagonism persistently increases dendritic spine densities in brain regions important to zebra finch vocal learning and production in an antidepressant-sensitive manner. Brain Res. 1672, 1\u20139 (2017).","journal-title":"Brain Res."},{"key":"1085_CR133","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.biopsych.2016.07.007","volume":"81","author":"R Saravia","year":"2017","unstructured":"Saravia, R. et al. CB1 cannabinoid receptors mediate cognitive deficits and structural plasticity changes during nicotine withdrawal. Biol. Psychiatry 81, 625\u2013634 (2017).","journal-title":"Biol. Psychiatry"},{"key":"1085_CR134","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neuroscience.2012.09.077","volume":"251","author":"DL Dickstein","year":"2013","unstructured":"Dickstein, D. L., Weaver, C. M., Luebke, J. I. & Hof, P. R. Dendritic spine changes associated with normal aging. Neuroscience 251, 21\u201332 (2013).","journal-title":"Neuroscience"},{"key":"1085_CR135","first-page":"487","volume":"27","author":"CK Walker","year":"2021","unstructured":"Walker, C. K. & Herskowitz, J. H. Dendritic spines: mediators of cognitive resilience in aging and Alzheimer\u2019s disease. Neuroscience 27, 487\u2013505 (2021).","journal-title":"Neuroscience"},{"key":"1085_CR136","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-27146-2","volume":"13","author":"JA Komorowska-M\u00fcller","year":"2023","unstructured":"Komorowska-M\u00fcller, J. A. et al. Chronic low-dose \u03949-tetrahydrocannabinol (THC) treatment stabilizes dendritic spines in 18-month-old mice. Sci. Rep. 13, 1390 (2023). Using in vivo microscopy, this study showed that chronic infusion of THC lead to a long-lasting increase in spine density in old mice, involving a mechanism that improved spine stability.","journal-title":"Sci. Rep."},{"key":"1085_CR137","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuron.2012.09.020","volume":"76","author":"PE Castillo","year":"2012","unstructured":"Castillo, P. E., Younts, T. J., Ch\u00e1vez, A. E. & Hashimotodani, Y. Endocannabinoid signaling and synaptic function. Neuron 76, 70\u201381 (2012).","journal-title":"Neuron"},{"key":"1085_CR138","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuropharm.2017.06.017","volume":"124","author":"A Araque","year":"2017","unstructured":"Araque, A., Castillo, P. E., Manzoni, O. J. & Tonini, R. Synaptic functions of endocannabinoid signaling in health and disease. Neuropharmacology 124, 13\u201324 (2017).","journal-title":"Neuropharmacology"},{"key":"1085_CR139","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.neuron.2012.08.019","volume":"75","author":"JJ Harris","year":"2012","unstructured":"Harris, J. J., Jolivet, R. & Attwell, D. Synaptic energy use and supply. Neuron 75, 762\u2013777 (2012).","journal-title":"Neuron"},{"key":"1085_CR140","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s10571-025-01555-z","volume":"45","author":"D Na","year":"2025","unstructured":"Na, D. et al. Energy metabolism and brain aging: strategies to delay neuronal degeneration. Cell. Mol. Neurobiol. 45, 38 (2025).","journal-title":"Cell. Mol. Neurobiol."},{"key":"1085_CR141","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1042\/EBC20220089","volume":"67","author":"I Fern\u00e1ndez-Moncada","year":"2023","unstructured":"Fern\u00e1ndez-Moncada, I. & Marsicano, G. Astroglial CB1 receptors, energy metabolism, and gliotransmission: an integrated signaling system? Essays Biochem. 67, 49\u201361 (2023).","journal-title":"Essays Biochem."},{"key":"1085_CR142","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.neuron.2018.04.034","volume":"98","author":"LM Robin","year":"2018","unstructured":"Robin, L. M. et al. Astroglial CB1 receptors determine synaptic D-serine availability to enable recognition memory. Neuron 98, 935\u2013944 https:\/\/doi.org\/10.1016\/j.neuron.2018.04.034 (2018).","journal-title":"Neuron"},{"key":"1085_CR143","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51008-2","volume":"15","author":"I Fern\u00e1ndez-Moncada","year":"2024","unstructured":"Fern\u00e1ndez-Moncada, I. et al. A lactate-dependent shift of glycolysis mediates synaptic and cognitive processes in male mice. Nat. Commun. 15, 6842 (2024).","journal-title":"Nat. Commun."},{"key":"1085_CR144","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/nrm4048","volume":"16","author":"BA Benayoun","year":"2015","unstructured":"Benayoun, B. A., Pollina, E. A. & Brunet, A. Epigenetic regulation of ageing: Linking environmental inputs to genomic stability. Nat. Rev. Mol. Cell Biol. 16, 593\u2013610 (2015). This comprehensive review summarizes important age-related changes in chromatin structure and discusses the impact of environmental stimuli.","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1085_CR145","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.molcel.2016.05.013","volume":"62","author":"LN Booth","year":"2016","unstructured":"Booth, L. N. & Brunet, A. The aging epigenome. Mol. Cell 62, 728\u2013744 (2016).","journal-title":"Mol. Cell"},{"key":"1085_CR146","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/hmg\/ddq561","volume":"20","author":"DG Hernandez","year":"2011","unstructured":"Hernandez, D. G. et al. Distinct DNA methylation changes highly correlated with chronological age in the human brain. Hum. Mol. Genet. 20, 1164\u20131172 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"1085_CR147","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3390\/ijms21031113","volume":"21","author":"R Meccariello","year":"2020","unstructured":"Meccariello, R. et al. The epigenetics of the endocannabinoid system. Int. J. Mol. Sci. 21, 1113 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1085_CR148","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.biopsych.2011.06.027","volume":"70","author":"JA DiNieri","year":"2011","unstructured":"DiNieri, J. A. et al. Maternal cannabis use alters ventral striatal dopamine D2 gene regulation in the offspring. Biol. Psychiatry 70, 763\u2013769 (2011).","journal-title":"Biol. Psychiatry"},{"key":"1085_CR149","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.3390\/ijms18102094","volume":"18","author":"P Prini","year":"2017","unstructured":"Prini, P., Penna, F., Sciuccati, E., Alberio, T. & Rubino, T. Chronic \u03949-THC exposure differently affects histone modifications in the adolescent and adult rat brain. Int. J. Mol. Sci. 18, 2094 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"1085_CR150","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1503\/jpn.170082","volume":"43","author":"P Prini","year":"2018","unstructured":"Prini, P. et al. Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex. J. Psychiatry Neurosci. 43, 87\u2013101 (2018).","journal-title":"J. Psychiatry Neurosci."},{"key":"1085_CR151","doi-asserted-by":"publisher","first-page":"e452","DOI":"10.1038\/tp.2014.99","volume":"4","author":"SL Hollins","year":"2014","unstructured":"Hollins, S. L., Zavitsanou, K., Walker, F. R. & Cairns, M. J. Alteration of imprinted Dlk1\u2013Dio3 miRNA cluster expression in the entorhinal cortex induced by maternal immune activation and adolescent cannabinoid exposure. Transl. Psychiatry 4, e452 (2014).","journal-title":"Transl. Psychiatry"},{"key":"1085_CR152","doi-asserted-by":"crossref","first-page":"NS20220034","DOI":"10.1042\/NS20220034","volume":"7","author":"AA Coelho","year":"2023","unstructured":"Coelho, A. A., Lima-Bastos, S., Gobira, P. H. & Lisboa, S. F. Endocannabinoid signaling and epigenetics modifications in the neurobiology of stress-related disorders. Neuronal Signal. 7, NS20220034 (2023).","journal-title":"Neuronal Signal."},{"key":"1085_CR153","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/jamapsychiatry.2022.3915","volume":"80","author":"J-MN Ferland","year":"2023","unstructured":"Ferland, J.-M. N. et al. Long-term outcomes of adolescent THC exposure on translational cognitive measures in adulthood in an animal model and computational assessment of human data. JAMA Psychiatry 80, 66\u201376 (2023).","journal-title":"JAMA Psychiatry"},{"key":"1085_CR154","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/can.2017.0034","volume":"2","author":"M Murphy","year":"2017","unstructured":"Murphy, M. et al. Chronic adolescent \u03949-tetrahydrocannabinol treatment of male mice leads to long-term cognitive and behavioral dysfunction, which are prevented by concurrent cannabidiol treatment. Cannabis Cannabinoid Res. 2, 235\u2013246 (2017).","journal-title":"Cannabis Cannabinoid Res."},{"key":"1085_CR155","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/sj.npp.1301475","volume":"33","author":"HR Quinn","year":"2008","unstructured":"Quinn, H. R. et al. Adolescent rats find repeated \u0394(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure. Neuropsychopharmacology 33, 1113\u20131126 (2008).","journal-title":"Neuropsychopharmacology"},{"key":"1085_CR156","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1038\/s41386-022-01413-2","volume":"47","author":"Y Zuo","year":"2022","unstructured":"Zuo, Y. et al. Chronic adolescent exposure to cannabis in mice leads to sex-biased changes in gene expression networks across brain regions. Neuropsychopharmacology 47, 2071\u20132080 (2022).","journal-title":"Neuropsychopharmacology"},{"key":"1085_CR157","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1016\/j.euroneuro.2015.09.021","volume":"25","author":"E Zamberletti","year":"2015","unstructured":"Zamberletti, E., Gabaglio, M., Prini, P., Rubino, T. & Parolaro, D. Cortical neuroinflammation contributes to long-term cognitive dysfunctions following adolescent \u0394-9-tetrahydrocannabinol treatment in female rats. Eur. Neuropsychopharmacol. 25, 2404\u20132415 (2015).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"1085_CR158","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.biopsych.2022.04.017","volume":"92","author":"H-L Lee","year":"2022","unstructured":"Lee, H.-L. et al. Frequent low-dose \u03949-tetrahydrocannabinol in adolescence disrupts microglia homeostasis and disables responses to microbial infection and social stress in young adulthood. Biol. Psychiatry 92, 845\u2013860 (2022).","journal-title":"Biol. Psychiatry"},{"key":"1085_CR159","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42276-5","volume":"14","author":"Y Hasegawa","year":"2023","unstructured":"Hasegawa, Y. et al. Microglial cannabinoid receptor type 1 mediates social memory deficits in mice produced by adolescent THC exposure and 16p11.2 duplication. Nat. Commun. 14, 6559 (2023).","journal-title":"Nat. Commun."},{"key":"1085_CR160","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1021\/acsptsci.4c00002","volume":"7","author":"A Bilkei-Gorzo","year":"2024","unstructured":"Bilkei-Gorzo, A. et al. Bidirectional effect of long-term \u03949-tetrahydrocannabinol treatment on mTOR activity and metabolome. ACS Pharmacol. Transl. Sci. 7, 2637\u20132649 (2024).","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"1085_CR161","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00406-019-00981-7","volume":"269","author":"C Gorey","year":"2019","unstructured":"Gorey, C., Kuhns, L., Smaragdi, E., Kroon, E. & Cousijn, J. Age-related differences in the impact of cannabis use on the brain and cognition: a systematic review. Eur. Arch. Psychiatry Clin. Neurosci. 269, 37\u201358 (2019).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"1085_CR162","doi-asserted-by":"crossref","first-page":"118902","DOI":"10.1016\/j.biopha.2025.118902","volume":"194","author":"SR Esteban","year":"2026","unstructured":"Esteban, S. R. et al. Treatment with a botanical mixture of cannabidiol:\u03949-tetrahydrocannabinol enhances microglial phagocytosis and shapes amyloid plaques in a mouse model of Alzheimer\u2019s disease. Biomed. Pharmacother. 194, 118902 (2026).","journal-title":"Biomed. Pharmacother."},{"key":"1085_CR163","doi-asserted-by":"crossref","first-page":"174101","DOI":"10.1016\/j.pbb.2025.174101","volume":"257","author":"B Aumer","year":"2025","unstructured":"Aumer, B. et al. Combination treatment with medium dose THC and CBD had no therapeutic effect in a transgenic mouse model for Alzheimer\u2019s disease but affected other domains including anxiety-related behaviours and object recognition memory. Pharmacol. Biochem. Behav. 257, 174101 (2025).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"1085_CR164","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-8","volume":"9","author":"AM Mart\u00edn-Moreno","year":"2012","unstructured":"Mart\u00edn-Moreno, A. M. et al. Prolonged oral cannabinoid administration prevents neuroinflammation, lowers \u03b2-amyloid levels and improves cognitive performance in Tg APP 2576 mice. J. Neuroinflammation 9, 8 (2012).","journal-title":"J. Neuroinflammation"},{"key":"1085_CR165","unstructured":"European Drug Report 2025. EUDA https:\/\/www.euda.europa.eu\/publications\/european-drug-report\/2025\/ (2025)."},{"key":"1085_CR166","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/add.14031","volume":"113","author":"WC Kerr","year":"2018","unstructured":"Kerr, W. C., Lui, C. & Ye, Y. Trends and age, period and cohort effects for marijuana use prevalence in the 1984\u20132015 US National Alcohol Surveys. Addiction 113, 473\u2013481 (2018).","journal-title":"Addiction"},{"key":"1085_CR167","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/add.13670","volume":"112","author":"BH Han","year":"2017","unstructured":"Han, B. H. et al. Demographic trends among older cannabis users in the United States, 2006\u201313. Addiction 112, 516\u2013525 (2017).","journal-title":"Addiction"},{"key":"1085_CR168","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/1874473710801020114","volume":"1","author":"G Jager","year":"2008","unstructured":"Jager, G. & Ramsey, N. Long-term consequences of adolescent cannabis exposure on the development of cognition, brain structure and function: an overview of animal and human research. Curr. Drug Abus. Rev. 1, 114\u2013123 (2008).","journal-title":"Curr. Drug Abus. Rev."},{"key":"1085_CR169","doi-asserted-by":"crossref","first-page":"afaf319","DOI":"10.1093\/ageing\/afaf319","volume":"54","author":"SR Sznitman","year":"2025","unstructured":"Sznitman, S. R., Vered, S. & Weinstein, G. History of cannabis use and cognitive function in older adults: findings from the UK biobank. Age Ageing 54, afaf319 (2025).","journal-title":"Age Ageing"},{"key":"1085_CR170","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/15504263.2019.1626030","volume":"16","author":"JC Duperrouzel","year":"2020","unstructured":"Duperrouzel, J. C., Granja, K., Pacheco-Col\u00f3n, I. & Gonzalez, R. Adverse effects of cannabis use on neurocognitive functioning: a systematic review of meta- analytic studies. J. Dual Diagn. 16, 43\u201357 (2020).","journal-title":"J. Dual Diagn."},{"key":"1085_CR171","doi-asserted-by":"crossref","first-page":"108434","DOI":"10.1016\/j.addbeh.2025.108434","volume":"170","author":"F Pilon","year":"2025","unstructured":"Pilon, F., Dumais, A., Gigu\u00e8re, C. -\u00c9. & Potvin, S. The effects of cannabis use disorder on cognitive functions: a meta-analysis. Addict. Behav. 170, 108434 (2025).","journal-title":"Addict. Behav."},{"key":"1085_CR172","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.biopsych.2015.12.002","volume":"79","author":"SJ Broyd","year":"2016","unstructured":"Broyd, S. J., van Hell, H. H., Beale, C., Y\u00fccel, M. & Solowij, N. Acute and chronic effects of cannabinoids on human cognition \u2014 a systematic review. Biol. Psychiatry 79, 557\u2013567 (2016).","journal-title":"Biol. Psychiatry"},{"key":"1085_CR173","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1073\/pnas.1215678110","volume":"110","author":"O Rogeberg","year":"2013","unstructured":"Rogeberg, O. Correlations between cannabis use and IQ change in the Dunedin cohort are consistent with confounding from socioeconomic status. Proc. Natl Acad. Sci. USA 110, 4251\u20134254 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1085_CR174","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/add.15207","volume":"116","author":"JM Ellingson","year":"2021","unstructured":"Ellingson, J. M. et al. Familial factors may not explain the effect of moderate-to-heavy cannabis use on cognitive functioning in adolescents: a sibling-comparison study. Addiction 116, 833\u2013844 (2021).","journal-title":"Addiction"},{"key":"1085_CR175","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.euroneuro.2020.03.012","volume":"36","author":"V Lorenzetti","year":"2020","unstructured":"Lorenzetti, V., Hoch, E. & Hall, W. Adolescent cannabis use, cognition, brain health and educational outcomes: a review of the evidence. Eur. Neuropsychopharmacol. 36, 169\u2013180 (2020).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"1085_CR176","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/CAD.0000000000000685","volume":"30","author":"G Bar-Sela","year":"2018","unstructured":"Bar-Sela, G. et al. Cannabis-related cognitive impairment: a prospective evaluation of possible influences on patients with cancer during chemotherapy treatment as a pilot study. Anticancer Drugs 30, 91\u201397 (2018).","journal-title":"Anticancer Drugs"},{"key":"1085_CR177","doi-asserted-by":"crossref","first-page":"101041","DOI":"10.1016\/j.arr.2020.101041","volume":"59","author":"G Weinstein","year":"2020","unstructured":"Weinstein, G. & Sznitman, S. R. The implications of late-life cannabis use on brain health: a mapping review and implications for future research. Ageing Res. Rev. 59, 101041 (2020). This review identifies age as a critical modifier of the cognitive effects of cannabis, finding preliminary evidence that late-life use may not share the adverse cognitive associations observed with early-life exposure.","journal-title":"Ageing Res. Rev."},{"key":"1085_CR178","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/aje\/kwr315","volume":"175","author":"A Dregan","year":"2012","unstructured":"Dregan, A. & Gulliford, M. C. Is illicit drug use harmful to cognitive functioning in the midadult years? A cohort-based investigation. Am. J. Epidemiol. 175, 218\u2013227 (2012).","journal-title":"Am. J. Epidemiol."},{"key":"1085_CR179","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jagp.2019.05.002","volume":"27","author":"N Herrmann","year":"2019","unstructured":"Herrmann, N. et al. Randomized placebo-controlled trial of nabilone for agitation in Alzheimer\u2019s disease. Am. J. Geriatr. Psychiatry 27, 1161\u20131173 (2019).","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"1085_CR180","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/mds.26142","volume":"30","author":"B Kluger","year":"2015","unstructured":"Kluger, B., Triolo, P., Jones, W. & Jankovic, J. The therapeutic potential of cannabinoids for movement disorders. Mov. Disord. 30, 313\u2013327 (2015).","journal-title":"Mov. Disord."},{"key":"1085_CR181","doi-asserted-by":"crossref","first-page":"301","DOI":"10.9758\/cpn.2017.15.4.301","volume":"15","author":"K Lim","year":"2017","unstructured":"Lim, K., See, Y. M. & Lee, J. A systematic review of the effectiveness of medical cannabis for psychiatric, movement and neurodegenerative disorders. Clin. Psychopharmacol. Neurosci. 15, 301\u2013312 (2017).","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"1085_CR182","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/ana.25864","volume":"88","author":"M Peball","year":"2020","unstructured":"Peball, M. et al. Non-motor symptoms in Parkinson\u2019s disease are reduced by nabilone. Ann. Neurol. 88, 712\u2013722 (2020).","journal-title":"Ann. Neurol."},{"key":"1085_CR183","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41531-024-00665-7","volume":"10","author":"M Peball","year":"2024","unstructured":"Peball, M. et al. Long-term safety and efficacy of open-label nabilone on sleep and pain in Parkinson\u00b4s disease. npj Parkinsons Dis. 10, 61 (2024).","journal-title":"npj Parkinsons Dis."},{"key":"1085_CR184","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/mdc3.13471","volume":"9","author":"M Peball","year":"2022","unstructured":"Peball, M. et al. Effects of nabilone on sleep outcomes in patients with Parkinson\u2019s disease: a post-hoc analysis of NMS-Nab study. Mov. Disord. Clin. Pract. 9, 751\u2013758 (2022).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"1085_CR185","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1177\/13872877251389608","volume":"108","author":"R Cury","year":"2025","unstructured":"Cury, R. et al. A randomized clinical trial of low-dose cannabis extract in Alzheimer\u2019s disease. J. Alzheimers Dis. 108, 1602\u20131613 (2025).","journal-title":"J. Alzheimers Dis."},{"key":"1085_CR186","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s42238-022-00119-y","volume":"4","author":"A Bahji","year":"2022","unstructured":"Bahji, A. et al. Cannabinoids in the management of behavioral, psychological, and motor symptoms of neurocognitive disorders: a mixed studies systematic review. J. Cannabis Res. 4, 11 (2022).","journal-title":"J. Cannabis Res."},{"key":"1085_CR187","first-page":"CD012820","volume":"2021","author":"DB Kuharic","year":"2021","unstructured":"Kuharic, D. B. et al. Cannabinoids for the treatment of dementia. Cochrane Database Syst. Rev. 2021, CD012820 (2021).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1085_CR188","first-page":"243","volume":"43","author":"F Stella","year":"2021","unstructured":"Stella, F. et al. Medical cannabinoids for treatment of neuropsychiatric symptoms in dementia: a systematic review. Trends Psychiatry Psychother. 43, 243\u2013255 (2021).","journal-title":"Trends Psychiatry Psychother."},{"key":"1085_CR189","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s40263-026-01277-w","volume":"40","author":"TJ Pan","year":"2026","unstructured":"Pan, T. J. et al. Efficacy and safety of cannabinoids for neuropsychiatric symptoms of dementia: a systematic review with meta-analysis. CNS Drugs 40, 669\u2013685 (2026).","journal-title":"CNS Drugs"},{"key":"1085_CR190","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1600-0447.2006.00859.x","volume":"115","author":"S Li","year":"2007","unstructured":"Li, S. et al. Is the dementia rate increasing in Beijing? Prevalence and incidence of dementia 10 years later in an urban elderly population. Acta Psychiatr. Scand. 115, 73\u201379 (2007).","journal-title":"Acta Psychiatr. Scand."},{"key":"1085_CR191","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jalz.2015.06.1894","volume":"12","author":"S Gao","year":"2016","unstructured":"Gao, S. et al. Dementia incidence declined in African-Americans but not in Yoruba. Alzheimers Dement. 12, 244\u2013251 (2016).","journal-title":"Alzheimers Dement."},{"key":"1085_CR192","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","volume":"404","author":"G Livingston","year":"2024","unstructured":"Livingston, G. et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing commission. Lancet 404, 572\u2013628 (2024).","journal-title":"Lancet"},{"key":"1085_CR193","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/jnnp-2024-334925","volume":"96","author":"J Senff","year":"2025","unstructured":"Senff, J. et al. Modifiable risk factors for stroke, dementia and late-life depression: a systematic review and DALY-weighted risk factors for a composite outcome. J. Neurol. Neurosurg. Psychiatry 96, 515\u2013527 (2025).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1085_CR194","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3390\/biomedicines11020306","volume":"11","author":"G D\u00f6rnyei","year":"2023","unstructured":"D\u00f6rnyei, G. et al. Role of the endocannabinoid system in metabolic control processes and in the pathogenesis of metabolic syndrome: an update. Biomedicines 11, 306 (2023).","journal-title":"Biomedicines"},{"key":"1085_CR195","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/glia.24580","volume":"72","author":"LG Allende","year":"2024","unstructured":"Allende, L. G. et al. Lysosomal cholesterol accumulation in aged astrocytes impairs cholesterol delivery to neurons and can be rescued by cannabinoids. Glia 72, 1746\u20131765 (2024).","journal-title":"Glia"},{"key":"1085_CR196","doi-asserted-by":"crossref","first-page":"1766980","DOI":"10.3389\/fpsyt.2026.1766980","volume":"17","author":"G Zhang","year":"2026","unstructured":"Zhang, G., Hu, Q. & Zou, H. Bridging reward and resilience: the endocannabinoid system as a unifying mechanism in exercise-induced protection against major depressive disorder. Front. Psychiatry 17, 1766980 (2026).","journal-title":"Front. Psychiatry"},{"key":"1085_CR197","doi-asserted-by":"crossref","first-page":"762738","DOI":"10.3389\/fphar.2021.762738","volume":"12","author":"I Gallego-Landin","year":"2021","unstructured":"Gallego-Landin, I., Garc\u00eda-Baos, A., Castro-Zavala, A. & Valverde, O. Reviewing the role of the endocannabinoid system in the pathophysiology of depression. Front. Pharmacol. 12, 762738 (2021).","journal-title":"Front. Pharmacol."},{"key":"1085_CR198","doi-asserted-by":"crossref","first-page":"241","DOI":"10.31887\/DCNS.2020.22.3\/rspanagel","volume":"22","author":"R Spanagel","year":"2020","unstructured":"Spanagel, R. Cannabinoids and the endocannabinoid system in reward processing and addiction: from mechanisms to interventions. Dialogues Clin. Neurosci. 22, 241\u2013250 (2020).","journal-title":"Dialogues Clin. Neurosci."},{"key":"1085_CR199","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.3390\/ijms24031989","volume":"24","author":"D Matei","year":"2023","unstructured":"Matei, D. et al. The endocannabinoid system and physical exercise. Int. J. Mol. Sci. 24, 1989 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1085_CR200","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/35097089","volume":"413","author":"D Panikashvili","year":"2001","unstructured":"Panikashvili, D. et al. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature 413, 527\u2013531 (2001).","journal-title":"Nature"},{"key":"1085_CR201","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1476-5381.2011.01343.x","volume":"163","author":"E Shohami","year":"2011","unstructured":"Shohami, E., Cohen-Yeshurun, A., Magid, L., Algali, M. & Mechoulam, R. Endocannabinoids and traumatic brain injury. Br. J. Pharmacol. 163, 1402\u20131410 (2011).","journal-title":"Br. J. Pharmacol."},{"key":"1085_CR202","doi-asserted-by":"crossref","first-page":"1148327","DOI":"10.3389\/fneur.2023.1148327","volume":"14","author":"V Bhat","year":"2023","unstructured":"Bhat, V., Onaivi, E. S. & Sharma, V. Endocannabinoid system components as potential neuroimmune therapeutic targets in tinnitus. Front. Neurol. 14, 1148327 (2023).","journal-title":"Front. Neurol."},{"key":"1085_CR203","doi-asserted-by":"crossref","first-page":"e71568","DOI":"10.1096\/fj.202502888RR","volume":"40","author":"S Palaniappan","year":"2026","unstructured":"Palaniappan, S. et al. Unraveling endocannabinoid signaling pathways in cisplatin-induced ototoxicity. FASEB J. 40, e71568 (2026).","journal-title":"FASEB J."},{"key":"1085_CR204","doi-asserted-by":"crossref","first-page":"1010296","DOI":"10.3389\/fphar.2022.1010296","volume":"13","author":"J Guerra","year":"2022","unstructured":"Guerra, J., Naidoo, V. & Cacabelos, R. Potential effects of cannabinoids on audiovestibular function: a narrative review. Front. Pharmacol. 13, 1010296 (2022).","journal-title":"Front. Pharmacol."},{"key":"1085_CR205","doi-asserted-by":"crossref","first-page":"104680","DOI":"10.1016\/j.neubiorev.2022.104680","volume":"138","author":"M Ahmed","year":"2022","unstructured":"Ahmed, M., Best, L. M., Pereira, C. F., Boileau, I. & Kloiber, S. Effects of endocannabinoid system modulation on social behaviour: a systematic review of animal studies. Neurosci. Biobehav. Rev. 138, 104680 (2022).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"1085_CR206","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3390\/ph16081149","volume":"16","author":"T Lindner","year":"2023","unstructured":"Lindner, T. et al. Therapeutic potential of cannabinoids in glaucoma. Pharmaceuticals 16, 1149 (2023).","journal-title":"Pharmaceuticals"},{"key":"1085_CR207","doi-asserted-by":"crossref","first-page":"e31373","DOI":"10.1002\/jcp.31373","volume":"239","author":"Y Guo","year":"2024","unstructured":"Guo, Y., Wei, X., Pei, J., Yang, H. & Zheng, X. Dissecting the role of cannabinoids in vascular health and disease. J. Cell. Physiol. 239, e31373 (2024).","journal-title":"J. Cell. Physiol."}],"container-title":["Nature Reviews Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41583-026-01085-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41583-026-01085-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41583-026-01085-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:08:49Z","timestamp":1792159729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41583-026-01085-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":207,"alternative-id":["1085"],"URL":"https:\/\/doi.org\/10.1038\/s41583-026-01085-7","relation":{},"ISSN":["1471-003X","1471-0048"],"issn-type":[{"value":"1471-003X","type":"print"},{"value":"1471-0048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"18 September 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}